Overview Request Sample Pages Request Customization Download PDF
You are viewing: Europe Bioinformatics Market analysis
Part of: Bioinformatics Market (Global)

The Europe Bioinformatics Market was valued at $5562.3 Million in 2026 and projected to reach to $10071.8 Million by 2031, representing a compound annual growth rate of 12.6%. Europe's bioinformatics market is poised for sustained expansion driven by increasing investments in genomic research, personalized medicine initiatives, and digital health transformation across the region.

Europe Bioinformatics Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Europe Bioinformatics Market Trends and Insights

  • This expansion reflects Europe's strong investment in genomic research, personalized medicine initiatives, and advanced healthcare infrastructure.
  • Europe is leveraging bioinformatics to enhance drug discovery, clinical diagnostics, and precision healthcare delivery across member states. The European bioinformatics sector is driven by regulatory support, collaborative research networks, and increasing adoption of AI-powered analytical tools.
  • Europe's commitment to data privacy through GDPR frameworks and substantial R&D funding positions the region as a leader in ethical bioinformatics innovation.
  • By 2031, Europe is expected to maintain its competitive edge through continued investment in computational biology and integrated healthcare solutions. Europe's bioinformatics market growth is underpinned by rising demand for genomic sequencing, biomarker discovery, and real-world evidence generation.
  • Europe's academic institutions and pharmaceutical companies are increasingly partnering to accelerate bioinformatics adoption, ensuring sustained market expansion through the forecast period..

Key Market Statistics

  • CAGR (2026-2031) 12.6% CAGR
  • Market Size, 2026 ~USD 5562.3 Million
  • Forecast, 2031 ~USD 10071.8 Million
  • Geography Europe

Europe Bioinformatics Market Overview

Market Valuation & Growth :

Europe's bioinformatics market is valued at $5,562.3 million in 2026 and is projected to reach $10,071.8 million by 2031, representing a robust 12.6% CAGR, demonstrating strong regional momentum in healthcare innovation.

Genomic Research Leadership :

Europe leads in genomic research initiatives and personalized medicine programs, with countries like Germany, UK, and France investing heavily in precision healthcare infrastructure and advanced bioinformatics capabilities.

Drug Discovery & Clinical Applications :

European bioinformatics solutions are accelerating drug discovery timelines and enhancing clinical diagnostics through sophisticated data analytics, positioning the region as a hub for precision medicine development.

Healthcare Infrastructure Advantage :

Europe's advanced healthcare systems and regulatory frameworks create an ideal environment for bioinformatics adoption, supporting integration of genomic data into clinical workflows and patient care protocols.

Europe Bioinformatics Market Dynamics

  • The market benefits from Europe's strong healthcare infrastructure, regulatory support for precision medicine, and collaborative research ecosystems spanning multiple countries.
  • Key growth drivers include rising adoption of AI-powered diagnostic tools, expansion of genomic databases, and integration of bioinformatics into clinical practice.
  • By 2031, the market is expected to nearly double, reflecting Europe's commitment to advancing precision healthcare and maintaining its competitive position in global bioinformatics innovation..

Market Ecosystem

logo-mobile

BIOINFORMATICS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Provides bioinformatics solutions for genomic data analysis, next-generation sequencing (NGS) workflows, molecular diagnostics, and life science research. Its platforms support sequencing data interpretation, variant analysis, and clinical research applications. Faster genomic data analysis, improved accuracy in variant interpretation, streamlined NGS workflows, enhanced research productivity, and support for precision medicine development.
Offers integrated sequencing and bioinformatics platforms for analyzing large-scale genomic data. Its solutions support applications in oncology, inherited disease research, population genomics, and clinical diagnostics through advanced sequencing data analysis. Efficient management of complex genomic datasets, improved disease identification, faster biomarker discovery, enhanced clinical decision-making, and acceleration of personalized medicine.
Provides bioinformatics software and genomic analysis platforms for sample-to-insight workflows, molecular diagnostics, clinical research, and next-generation sequencing data interpretation. Simplified data analysis, improved workflow automation, reliable genomic insights, reduced analysis time, and enhanced support for molecular testing and precision healthcare.
Develops bioinformatics tools for genomics, transcriptomics, and molecular analysis, supporting applications such as microarray analysis, NGS data interpretation, and biomarker discovery in research and clinical settings. Improved data visualization and interpretation, increased research efficiency, accurate molecular profiling, faster discovery of biological insights, and optimized laboratory workflows.
Provides integrated bioinformatics solutions supporting clinical genomics, companion diagnostics, oncology research, and precision medicine. Its platforms enable genomic data analysis for targeted therapies and biomarker identification. Enhanced biomarker assessment, faster treatment decisions, improved diagnostic accuracy, optimized clinical workflows, and support for personalized medicine approaches.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

Related Ecosystem

Healthcare It

Top Technologies
  • Computed Tomography (CT)
  • Machine Learning
  • Magnetic Resonance Imaging (MRI)
  • Natural Language Processing (NLP)
  • Predictive Analytics
Top Companies
  • CERNER CORPORATION
  • PHILIPS HEALTHCARE
  • Oracle Corporation
  • GE HealthCare Technologies Inc.
  • Siemens healthineers

    Pharmaceuticals

    Top Technologies
    • Bioreactors
    • Analytical Testing
    • Bioanalytical Testing Services
    • Cell Counters
    • Data Management Services
    Top Companies
    • Thermo Fisher Scientific Inc.
    • SANOFI
    • Merck KGaA
    • NOVARTIS
    • Pfizer Inc.

      Key Takeaways

      • Europe's bioinformatics market will nearly double from $5,562.3M (2026) to $10,071.8M (2031), growing at a 12.6% CAGR.
      • Europe leads in ethical bioinformatics innovation through GDPR compliance and robust data governance frameworks.
      • Europe's strong academic-industry partnerships and R&D funding drive adoption of AI-powered genomic and diagnostic tools.
      • Europe's personalized medicine and precision healthcare initiatives are key growth catalysts through 2031.

      Bioinformatics Market Report Scope

      Report Metric Details
      Base Year 2026
      Fastest Growing Segment PRECISION MEDICINE (Use Case)
      Forecast Period 2026-2031
      Growth Rate CAGR of 13.1% from 2026 to 2031
      Largest Segment SOFTWARE (Offering)
      Market Size Base Year (Billions) ~USD 18.59 (2026)
      Revenue Forecast (Billions) ~USD 34.41 (2031)
      Segments Covered Offering, Type, Function, Use Case, Sector, End User

      Europe Bioinformatics Market Report Segmentation

      6 segment dimensions are covered across the global market.

      By Offering

      • Services
      • Software

      By Type

      • Chemoinformatics Solutions
      • Cloud & Managed Bioinformatics
      • Cloud & Managed Services
      • Consulting & Custom Bioinformatics Development
      • Data Analysis & Interpretation
      • Database & Data Management
      • Drug Discovery & Target Identification
      • End-To-End Solutions
      • Gene Expression Analysis
      • Generalized Knowledge Management Tools
      • Genomics Solutions
      • Knowledge Management Tool
      • Metabolomics Solutions
      • Multi-Omics Solutions
      • Multiomics Solutions
      • Niche Point Solutions
      • Other Bioinformatics Services
      • Other Data Analysis Functions
      • Other End-To-End Solutions
      • Other Services
      • Proteomics Solutions
      • Sequence Analysis
      • Sequencing & Data Generation
      • Specialized Knowledge Management Tools
      • Transcriptomics Solutions
      • Variant Analysis

      By Function

      • Clinical Interpretation
      • Data Analysis
      • Data Visualization & Reporting
      • Multiomics Integration
      • Other Functions
      • Structural & Functional Analysis

      By Use Case

      • Biomarker Discovery
      • Clinical Diagnostics
      • Drug Discovery & Development
      • Other Use Cases
      • Precision Medicine
      • Research & Academic Applications

      By Sector

      • Animal Biotechnology
      • Environmental Biotechnology
      • Forensic Biotechnology
      • Medical Biotechnology
      • Other Sectors
      • Plant Biotechnology

      By End User

      • Academic & Research Institutes
      • Contract Research Organizations And Contract Development & Manufacturing Organizations
      • Government & Public Health Organizations
      • Hospitals & Clinical Diagnostic Laboratories
      • Other End Users
      • Pharmaceutical & Biotechnology Companies

      Target Audience

      • Bioinformatics Software Vendors : Evaluate European market expansion opportunities, identify high-growth segments in genomic analysis and clinical diagnostics, and develop region-specific product strategies aligned with precision medicine trends.
      • Pharmaceutical & Biotech Companies : Leverage European bioinformatics capabilities to accelerate drug discovery, optimize clinical trial design, and enhance personalized medicine offerings across major European markets.
      • Healthcare IT Investors : Identify investment opportunities in Europe's growing bioinformatics sector, assess market valuations by country, and evaluate portfolio companies' competitive positioning in precision healthcare.
      • Clinical Diagnostics Providers : Understand European demand for advanced diagnostic solutions powered by bioinformatics, regulatory requirements, and reimbursement landscapes across Germany, UK, France, and other key markets.
      • Research Institutions & Academic Centers : Access market intelligence on genomic research funding, personalized medicine initiatives, and bioinformatics infrastructure investments to guide research priorities and collaboration strategies across Europe.

      Key Companies in the Europe Bioinformatics Market

      CompanyHQOwnershipStrongest segments
      BECKMAN COULTERUnited StatesPrivate CompanyBioinformatics Software (Genomics, Multiomics, Proteomics),Bioinformatics Services (Analysis, Sequencing, Genomic Services),
      WUXI APPTECChinaPublic CompanyChemical Business,Testing Services,Biological Services,
      DANAHER CORPORATIONUnited StatesPublic CompanyDiagnostics,Life Sciences (Excl. Biotechnology),Biotechnology,
      THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
      ILLUMINA, INC.United StatesPublic CompanySequencing and array-based instruments,Consumables (reagents, flow cells, library preparation, WGS and targeted kits),Services (whole-genome sequencing, genotyping, NIPT, product support, informatics services),
      QIAGEN N.V.NetherlandsPublic CompanyBioinformatics software (genomics, multiomics, proteomics),Bioinformatics-linked services (analysis, sequencing, interpretation),Non-bioinformatics consumables and instruments,
      AGILENT TECHNOLOGIES, INC.United StatesPublic CompanyAgilent CrossLab,Life Sciences and Diagnostics Markets,Applied Markets,
      REVVITY, INC.United StatesPublic CompanyLife Sciences,Diagnostics,
      EUROFINS SCIENTIFICLuxembourgPublic CompanyBioinformatics-linked genomics and multiomics services,Non-informatics analytical testing (food, environment, consumer, other),
      BGI GENOMICSChinaPublic CompanySequencing and Bioinformatics Services,Clinical Testing and Precision Medicine Solutions,Mass Spectrometry and Multi-omics (Proteomics, Metabolomics, Multi-omics Integration),
      WATERS CORPORATIONUnited StatesPublic CompanyWaters Segment (LC-MS systems, consumables, and software),Materials Sciences Division (thermal analysis, rheometry, calorimetry),
      OXFORD NANOPORE TECHNOLOGIES PLCUnited KingdomPublic CompanySequencing instruments (MinION, GridION, PromethION),Consumables and flow cells,Software and bioinformatics services,
      10X GENOMICSUnited StatesPublic CompanySingle-cell and spatial instruments (Chromium, Chromium X Series, Visium, Xenium Analyzer, CytAssist),Consumables and reagents (microfluidic chips, slides, kits including QuantumScale),Bioinformatics software and analysis services (Cell Ranger, Loupe Browser, Xenium Explorer, associated analysis support),
      PACBIOUnited StatesPublic CompanySequencing instruments (Revio, Vega, Sequel, Onso),Consumables (SMRT cells, SMRTbell prep kits, binding and sequencing kits),Software and services (bioinformatics analysis, sequencing services, collaborations),
      SIEMENS AGGermanyPublic CompanyIndustrial Businesses (IB) - Siemens Healthineers,Industrial Businesses (IB) - Smart Infrastructure,Industrial Businesses (IB) - Digital Industries,
      SOPHIA GENETICSSwitzerlandPublic CompanySOPHiA DDM Software Platform (Genomics, Multiomics, Proteomics),Services (Analysis Support, Sequencing-Linked Informatics, Implementation),

      BECKMAN COULTER

      Beckman Coulter is a private American company founded in 1935 that employs 11,900 people. The company operates in the life sciences and diagnostics sector.

      WUXI APPTEC

      WuXi AppTec is a public Chinese company founded in 2000 with 35,584 employees. The company provides pharmaceutical and biotechnology research and development services.

      DANAHER CORPORATION

      Danaher Corporation is a public American company founded in 1969 with 59,000 employees. The company operates across multiple sectors including life sciences, diagnostics, and environmental solutions.

      THERMO FISHER SCIENTIFIC INC.

      Thermo Fisher Scientific Inc. is a public American company founded in 1956 with 125,000 employees. The company is a leading provider of laboratory equipment, reagents, and services for life sciences research and diagnostics.

      ILLUMINA, INC.

      Illumina, Inc. is a public American company founded in 1998 with 8,625 employees. The company specializes in DNA sequencing and genetic analysis technologies.

      QIAGEN N.V.

      QIAGEN N.V. is a public Dutch company founded in 1984 with 5,500 employees. The company develops and manufactures molecular diagnostics and life sciences products.

      AGILENT TECHNOLOGIES, INC.

      Agilent Technologies, Inc. is a public American company founded in 1999 with 18,000 employees. The company provides analytical instruments, software, and services for life sciences and diagnostics.

      REVVITY, INC.

      Revvity, Inc. is a public American company founded in 1937 with 11,000 employees. The company provides analytical instruments and life sciences solutions.

      EUROFINS SCIENTIFIC

      Eurofins Scientific is a public Luxembourg-based company founded in 1987 with 65,694 employees. The company operates a network of laboratories providing testing and analytical services across multiple industries.

      BGI GENOMICS

      BGI Genomics is a public Chinese company founded in 1999 with 3,580 employees. The company specializes in genomic sequencing and genetic analysis services.

      WATERS CORPORATION

      Waters Corporation is a public American company founded in 1958 with 7,900 employees. The company manufactures analytical instruments and software for laboratory testing and research.

      OXFORD NANOPORE TECHNOLOGIES PLC

      Oxford Nanopore Technologies PLC is a public British company founded in 2005 with 1,316 employees. The company develops nanopore-based DNA and RNA sequencing technologies.

      10X GENOMICS

      10X Genomics is a public American company founded in 2012 with 1,178 employees. The company develops single-cell and spatial genomics solutions for research and diagnostics.

      PACBIO

      PacBio is a public American company founded in 2000 with 485 employees. The company develops long-read DNA sequencing technologies and systems.

      SIEMENS AG

      Siemens AG is a public German company founded in 1847 with 317,000 employees. The company operates across multiple sectors including industrial automation, energy, healthcare, and infrastructure.

      SOPHIA GENETICS

      Sophia Genetics is a public Swiss company founded in 2011 with 415 employees. The company provides AI-powered genomic analysis and interpretation software for clinical diagnostics.

      Europe vs. other regions

      HowEurope compares to the other 3 regional blocs covered in this market.

      North America
      ~USD 14624.3 Million · 13.2% wtd CAGR ·
      Asia Pacific
      ~USD 7120.8 Million · 14.2% wtd CAGR ·
      Latin America
      ~USD 1635.8 Million · 11.9% wtd CAGR ·
      Middle East & Africa
      ~USD 960.4 Million · 10.2% wtd CAGR ·

      Countries within Europe - compare and drill down

      Country2025 size (native)
      GermanyUSD 2870.3 Million
      UKUSD 2365.3 Million
      FranceUSD 1629.4 Million
      ItalyUSD 857.5 Million
      SpainUSD 675.9 Million
      Rest Of EuropeUSD 1673.4 Million

      Country market size visualization

      Germany
      USD 2870.3 Million
      UK
      USD 2365.3 Million
      France
      USD 1629.4 Million
      Italy
      USD 857.5 Million
      Spain
      USD 675.9 Million
      Rest Of Europe
      USD 1673.4 Million

      Reasons to Buy this Report

      • Regional Market Sizing & Forecasts : Access detailed market valuations for Europe's bioinformatics sector with country-level breakdowns, enabling precise investment decisions and competitive positioning strategies across the region.
      • Growth Trajectory Analysis : Understand Europe's 12.6% CAGR trajectory through 2031, identifying emerging opportunities in genomic research, precision medicine, and clinical diagnostics across major European markets.
      • Country-Specific Intelligence : Gain insights into leading European markets including Germany ($2.87B), UK ($2.37B), and France ($1.63B), with tailored strategies for each country's unique healthcare landscape and regulatory environment.
      • Competitive Landscape Mapping : Benchmark your organization against regional competitors and identify market gaps in Europe's bioinformatics ecosystem, from drug discovery platforms to clinical diagnostic solutions.
      • Strategic Investment Guidance : Make informed decisions on market entry, partnerships, and product development in Europe by leveraging comprehensive data on healthcare infrastructure, research initiatives, and personalized medicine adoption rates.

      Frequently asked questions

      What is the projected size of Europe's bioinformatics market by 2031?

      Europe's bioinformatics market is projected to reach $10,071.8 million by 2031, up from $5,562.3 million in 2026, representing a 12.6% compound annual growth rate.

      What are the primary drivers of bioinformatics growth in Europe?

      Europe's bioinformatics growth is driven by increased genomic research investment, personalized medicine adoption, AI-powered analytical tools, GDPR-compliant data governance, and strong academic-industry collaborations.

      How does Europe's regulatory environment support bioinformatics development?

      Europe's GDPR framework ensures data privacy and ethical bioinformatics practices, while substantial public R&D funding and collaborative research networks accelerate innovation in computational biology and precision healthcare.

      Which applications are driving Europe's bioinformatics market expansion?

      Key applications include genomic sequencing, biomarker discovery, drug discovery acceleration, clinical diagnostics, and real-world evidence generation for personalized medicine and precision healthcare delivery.

      What is Europe's competitive advantage in the global bioinformatics market?

      Europe's competitive advantages include strong regulatory frameworks, ethical innovation standards, robust academic institutions, substantial R&D investment, and integrated healthcare systems supporting bioinformatics adoption.

      RESEARCH METHODOLOGY

      This research study involved the extensive use of both primary and secondary sources. It analyzed various factors affecting the industry to identify segmentation types, industry trends, key players, the competitive landscape of market players, and key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies.

      Secondary Research

      This research study extensively used secondary sources, including directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva, as well as white papers, annual reports, and companies' house documents. The secondary research aimed to gather and analyze information for a comprehensive, commercially focused study of the bioinformatics market, covering technical aspects and market dynamics. It also helped identify key players, market classifications, industry trends, geographic markets, and significant market developments. Additionally, a database of prominent industry leaders was compiled through secondary research.

      Primary Research

      In the primary research process, various supply-side and demand-side sources were interviewed to gather qualitative and quantitative information for this report. Primary supply-side sources included industry experts such as CEOs, VPs, managing directors, marketing and sales heads/directors, marketing managers, regional/area sales managers, and bioinformatics scientists. Primary demand-side sources included personnel from pharmaceutical and biotechnology companies, hospitals, diagnostic laboratories, and academic and research institutes.

      A breakdown of the primary respondents is provided below:

      Bioinformatics Market Size, and Share

      *Others include sales managers, marketing managers, and product managers.
      Note: Tiers are defined based on a company’s total revenue, as of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      The total size of the bioinformatics market was determined after data triangulation using the two approaches outlined below. After each approach was completed, the weighted average of the two approaches was calculated based on the level of assumptions used in each approach.

      Bioinformatics Market : Top-Down and Bottom-Up Approach

      Bioinformatics Market Top Down and Bottom Up Approach

      Data Triangulation

      The size of the bioinformatics market was estimated through segmental extrapolation using the bottom-up approach. The methodology is as follows:

      • Revenue information of individual companies was gathered from public sources and databases.
      • The share of leading players in the bioinformatics market was obtained from secondary sources to the extent available. In certain cases, shares of bioinformatics businesses have been ascertained after a detailed analysis of various parameters, including product portfolios, market positioning, selling price, and geographic reach and strength. 
      • Individual shares or revenue estimates were validated through interviews with experts.
      • The total revenue in the bioinformatics market was determined by extrapolating the market share data of major companies.

      Market Definition

      Bioinformatics is the application of computer technology to the management and analysis of biological data. It encompasses the storage, analysis, and dissemination of biological data. Bioinformatics uses computer programs for a variety of applications, including determining gene and protein functions, establishing evolutionary relationships, and predicting the three-dimensional shapes of proteins.

      Key Stakeholders

      • Bioinformatics software and service providers
      • Academic & research institutes
      • Clinical & diagnostic laboratories
      • Hospitals & healthcare providers
      • Contract research organizations (CROs)
      • Distributors and suppliers of bioinformatics software and services
      • Pharmaceutical & biotechnology companies
      • Market research and consulting firms
      • Venture capitalists

      Report Objectives

      • To define, describe, and forecast the bioinformatics market based on offering, function, use case, sector, end user, and region
      • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
      • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall bioinformatics market
      • To analyze opportunities for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa.
      • To profile the key players and analyze their market share and core competencies2
      • To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, and collaborations in the overall bioinformatics market
      • To benchmark players within the market using the proprietary "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy.

      Available customizations:

      With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

      • Company Information
      • Detailed analysis and profiling of additional market players (up to 5)

      Product Analysis

      • Further breakdown of the Rest of Asia Pacific market into Taiwan, New Zealand, Thailand, Singapore, Malaysia, and other countries
      • Further breakdown of the Rest of Europe bioinformatics market into Russia, Austria, Finland, Turkey, Norway, Poland, Portugal, Romania, Denmark, and other countries

      Get the Full Bioinformatics Market Report

      Full forecast, segment splits, and company analysis for all Bioinformatics Market.

      Download Sample Pages Buy Report

      METHODOLOGY

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      Cite this Research
      DMCA.com Protection Status